Enliven Therapeutics (ELVN)
Nasdaq • ELVN • US29337E1029
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 15.7% of free float sold short, 6 days to cover, cost to borrow 0.53%. Sign up for live short interest data.
Market Cap
3.77b USD | # 2935 in US
Volume
1.33m shares | 66.24m USD
Shares Outstanding
73.6m
Free Float Shares
82.67% | 60.84m
